Regulatory1 min read·Edition #13

DOJ Argues RFK Jr. Has Broad Discretion to Reshape Vaccine Policy Without Strict Evidence Standards

The Department of Justice defended RFK Jr.'s authority to unilaterally modify the childhood vaccine schedule and federal vaccine advisory committee composition, arguing he has wide discretion to choose which evidence to consider — a position that could fundamentally alter vaccine policy without new legislation.

This legal argument, made during federal court proceedings challenging Kennedy's changes, has immediate and severe implications for pediatric practices, family medicine clinics, and immunization programs. Kennedy has already modified the childhood vaccine schedule and reconstituted the vaccine advisory committee; if courts uphold the DOJ's position, he can continue doing so without statutory constraint. The question posed by the litigation — whether Kennedy could theoretically mandate measles exposure to reach herd immunity — illustrates the scope of potential disruption. For practices, this creates operational and liability chaos: changing vaccine schedules mid-year disrupts supply chains, patient education, billing codes, and insurance contracts. Parents will demand justification for contradictions between federal recommendations and what their pediatrician recommends. Malpractice insurers will face new risk categories. Practices in pro-vaccine communities will face backlash; those in skeptical communities will face pressure from health departments. Pediatric practices, already operating on thin margins (3–5% net), cannot absorb the operational burden of navigating competing federal guidance.

Practice leaders should document current vaccine protocols immediately and consult employment counsel on vaccine mandate policies. Pediatricians should review their state medical board's position on vaccine recommendations to understand liability exposure. DSOs with pediatric portfolios need contingency plans for patient volume swings if vaccination rates shift. Healthcare executives should anticipate increased reimbursement volatility — if immunization rates drop, preventive care payments decline, and acute-care utilization rises downstream. This case will likely reach appellate courts; timing remains uncertain.

Watch for: The federal judge's ruling on whether Kennedy's changes must be reversed and any appeals or legislative response from Congress.

More from Edition #13